SMC - January 2019 decisions

14 January 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Perjeta given green light in Scotland as early stage breast cancer treatment

10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for ...

Read more →

SMC - December 2018 decisions

10 December 2018 - A medicine used to treat early stage breast cancer has been accepted by the SMC for ...

Read more →

SMC - November 2018 decisions

12 November 2018 - A medicine used to treat a rare cancer which occurs predominantly in very young children has ...

Read more →

Revised process for ultra-orphan medicines

8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...

Read more →

SMC - October 2018 decisions

8 October 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...

Read more →

Scotland could be 'world leader' in precision medicine, says First Minister

9 September 2018 - Scotland has the potential to be a "world leader" in precision medicine, according to the first ...

Read more →

SMC - September 2018 decisions

10 September 2018 - The Scottish Medicines Consortium, has today published advice accepting four new medicines for use by NHSScotland.  ...

Read more →

NHS Scotland works up 'detailed' no-deal Brexit plan

21 August 2018 - Scotland's NHS has drawn up "detailed plans" to ensure enough medicine and equipment in the event ...

Read more →

SMC - August 2018 decisions

13 August 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...

Read more →

Time to entry for new cancer medicines: from European Union wide marketing authorisation to patient access in Belgium, Estonia, Scotland, and Sweden

10 July 2018 - This study quantified the median time from European Union wide approval to first use for a ...

Read more →

SMC rejects ocrelizumab (Ocrevus) for relapsing remitting MS in Scotland

9 July 2018 - The MS Trust is very disappointed that the Scottish Medicines Consortium is unable to recommend ocrelizumab as ...

Read more →

SMC - July 2018 decisions

9 July 2018 - The SMC, which advises NHSScotland on newly licensed medicines, has today published advice accepting three new medicines. ...

Read more →

Drug approved for leukaemia treatment

11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia ...

Read more →

SMC approves funding for six new therapies on the NHS

12 June 2018 - The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options ...

Read more →